- Home
- TWIN vs FENC Comparison
TWIN vs FENC Comparison
Compare TWIN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | FENC |
|---|---|---|
| Founded | 1918 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 230.8M |
| IPO Year | 1994 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TWIN | FENC |
|---|---|---|
| Price | $23.26 | $10.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 178.6K | ★ 193.6K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.76 | 0.01 |
| Revenue | ★ $340,738,000.00 | $44,642,000.00 |
| Revenue This Year | $10.79 | $65.12 |
| Revenue Next Year | $8.43 | $41.08 |
| P/E Ratio | ★ $13.13 | $1,015.00 |
| Revenue Growth | ★ 15.45 | N/A |
| 52 Week Low | $8.03 | $5.65 |
| 52 Week High | $24.50 | $11.31 |
Technical Indicators
Market Signals| Indicator | TWIN | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | 48.70 |
| Support Level | $14.75 | $10.04 |
| Resistance Level | $24.16 | $10.45 |
| Average True Range (ATR) | 1.28 | 0.56 |
| MACD | -0.07 | -0.12 |
| Stochastic Oscillator | 73.02 | 20.07 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.